D. Douglas Miller, M.D., C.M., M.B.A.
Dean of Medicine | New York Medical College
Valhalla, NY, UNITED STATES
D. Douglas Miller is dean of the School of Medicine at New York Medical College.
Media
Publications:
Documents:
Videos:
Audio/Podcasts:
Biography
D. Douglas Miller, M.D., C.M., M.B.A., dean of the School of Medicine since December 2014, came to NYMC from the University of Alberta where he served as dean of faculty of medicine and dentistry as well as chair of the Health Sciences Council. An internationally recognized cardiologist and clinician-scientist, Dr. Miller has served as a leader in academic medicine and chief academic/executive officer for more than 25 years.
Prior to the University of Alberta, Dr. Miller served as dean of the School of Medicine at the Medical College of Georgia (MCG). He has held clinical appointments as an internist, cardiologist and medical imager at the University of Texas Health Sciences Center San Antonio, Saint Louis University and the Veterans Administration.
Dr. Miller was the Robert G. Petersdorf Scholar-in-Residence with the Association of American Medical Colleges, where he studied the associations between national economies, health care policies and physician workforce balance. He received his undergraduate degree at Concordia University in Montreal, and attended medical school at McGill University where he also completed an internal medicine residency. He completed a clinical and research cardiology fellowship at l'Institut de Cardiologie de Montréal, a clinical cardiology fellowship at Emory University School of Medicine and a cardiac imaging fellowship at Harvard University. He later went on to receive an executive master of international business administration from Saint Louis University.
Industry Expertise (4)
Medical/Dental Practice
Health Care - Services
Education/Learning
Research
Areas of Expertise (5)
Academic Medicine
General Cardiology
Nuclear Cardiology
Health Care Policy
Medical Education
Accomplishments (2)
Cardiac Imaging Fellowship (professional)
1986-01-01
Harvard Medical School
Fellow of the American College of Cardiology (professional)
1984-01-01
Emory University School of Medicine Cardiovascular Disease Residency Program
Education (2)
Saint Louis University: M.B.A., International Business 1999
McGill University: M.D., Medicine 1978
Internal Medicine Residency Program.
Affiliations (2)
- Global Health Leadership Forum : Director
- Watson Health : Board Member
Languages (2)
- French
- English
Media Appearances (13)
Philips to advance cancer treatment with New York Medical College collaboration
Becker's Health IT & CIO Review online
2016-12-07
"We are excited to announce Phillips Healthcare Research as our biotech/high-tech incubator's new anchor tenant," said D. Douglas Miller, MD, dean of the school of medicine at NYMC, vice-provost for biomedical affairs and chief scientific officer of BioInc@NYMC. "The computational genomics collaboration between NYMC and Philips promises both research and economic benefits."
Philips Joins BioInc@NYMC Valhalla Incubator
The Business Journal online
2016-12-07
For New York Medical College, landing Philips helps strengthen the biotech incubator initiative that administrators view as crucial to what D. Douglas Miller, dean of the School of Medicine and chief science officer at BioInc@NYMC, describes as a rapidly changing medical field.
Philips Strengthens Collaboration with Leading Medical and Academic Institutions
CityBizList online
2016-12-06
"BioInc@NYMC is a thriving member of both the Westchester and the greater New York innovation ecosystem. We are excited to announce Phillips Healthcare Research as our biotech/high-tech incubator's new anchor tenant. The computational genomics collaboration between NYMC and Philips promises both research and economic benefits. Philips Healthcare Research and BioInc@NYMC's other clients are working every day to develop novel technologies and healthcare solutions," said D. Douglas Miller, M.D., C.M., M.B.A., Dean of the School of Medicine at New York Medical College, Vice-Provost for Biomedical Affairs and Chief Scientific Officer of BioInc@NYMC.
Philips Strengthens Collaboration with Leading Medical and Academic Institutions to Innovate in Personalized Health Solutions
Yahoo Finance online
2016-12-06
"BioInc@NYMC is a thriving member of both the Westchester and the greater New York innovation ecosystem. We are excited to announce Phillips Healthcare Research as our biotech/high-tech incubator's new anchor tenant. The computational genomics collaboration between NYMC and Philips promises both research and economic benefits. Philips Healthcare Research and BioInc@NYMC's other clients are working every day to develop novel technologies and healthcare solutions," said D. Douglas Miller, M.D., C.M., M.B.A., Dean of the School of Medicine at New York Medical College, Vice-Provost for Biomedical Affairs and Chief Scientific Officer of BioInc@NYMC.
BioInc@NYMC Continues to Expand and Grow
HVEDC Insights online
2016-11-22
In two short years, BioInc@NYMC, NY BioHud Valley’s biotechnology incubator, has grown from a fledgling initiative to one of the most successful interfaces between biotechnology and business in the region
Heart Walk Draws Crowd To Support Heart, Stroke & Pediatric Research
Hospital Newspaper online
2016-10-23
The Heart Walk, led by volunteer Executive Champion, Dr. D. Douglas Miller, Dean of New York Medical College, is the AHA’s biggest annual event, raising more than $343,500 for AHA programs and research at last year’s event. Funds raised at the Heart Walk will support research, so doctors can help prevent and treat heart disease, stroke and pediatric heart disease.
Walk For Your Heart At The Heart Walk October 2nd At Kensico Dam
Hospital Newspaper online
2016-09-26
Cardiovascular disease (CVD) is the No. 1 killer of all Americans. In fact, someone dies from CVD every 39 seconds. Heart disease also kills more women than all forms of cancer combined. And congenital cardiovascular defects are the most common cause of infant death from birth defects. The American Heart Association invites the public to join the October 2nd Heart Walk event at Kensico Dam to join the fight against heart disease and help save lives. Registration is open online at www.westchesterheartwalk.org. D. Douglas Miller, M.D., C.M., M.B.A., will serve as Executive Champion the Westchester Heart Walk event.
Valhalla: Westchester Heart Walk
Best Events online
2016-08-04
D. Douglas Miller, M.D., C.M., M.B.A., will serve as Executive Champion the Westchester Heart Walk event this year. Dr. Miller is Dean of the School of Medicine at New York Medical College in Valhalla.
BioInc@NYMC Welcomes Biotechnology Company Sapience Therapeutics
BioSpace online
2016-08-03
“BioInc@NYMC continues to support young companies that are tackling global health issues,” said Douglas Miller M.D., C.M., M.B.A., dean of the School of Medicine at New York Medical College. “Sapience Therapeutics has licensed intellectual property from Columbia University from which the company is developing novel solutions in the field of oncology. Sapience will serve to enrich the BioInc culture that is making strides to improve the world through the use of biotechnology and medicine.”
New York Medical College Hosts Class of 2019 White Coat Ceremony
Patch.com
2015-08-07
New York Medical College last week welcomed 200 new medical students with a gathering of friends and families on campus for the Class of 2019 White Coat Ceremony, the Valhalla-based school announced.
Biogen Idec Gives $1.4M to New MS Research Program in Alberta
Multiple Sclerosis News Today online
2014-11-07
The dean of the university’s Faculty of Medicine & Dentistry, D. Douglas Miller, said the new program follows the inauguration of the Neuroscience and Mental Health Institute. He believes this public-private collaboration will only strengthen the parties’ positions in MS research and development, and bring much-needed knowledge and relief to the MS community...
University of Alberta med school receives ‘gold-plated’ accreditation
Global News online
2014-07-07
“As the last medical school in North America to undergo both CACMS and LCME accreditation, it is gratifying to see that this robust review of our MD program revealed no deficiencies and several strengths,” said Dr. D. Douglas Miller, dean of the medicine and dentistry faculty...
MCG aims to expand class size with new building
The Augusta Chronicle online
2010-05-14
Despite a rapid rise in research funding and the amount of funding per scientist, Medical College of Georgia School of Medicine must adapt quickly to meet tremendous changes, the school's dean said Friday. It must also get a new building if it is going to meet targets for expanding medical education in Augusta, Dr. D. Douglas Miller said...
Patents (2)
Interleukin Receptor Targeted Molecules for Treatment of Atherosclerosis
US5326559 A
1994-07-05
The invention features a method for treating accelerated atherosclerosis in a patient suffering from vascular damage ...
System for Proton Bean Irradiation and Magnetic Resonance Imaging
US6725078 B2
2004-04-20
A system which coordinates proton beam irradiation with an open magnetic resonance imaging (MRI) unit to achieve near-simultaneous, noninvasive localization and radiotherapy of various cell lines in various anatomic locations.
Articles (selected) (5)
Impact of Diabetes on the Risk Stratification Using Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging in Patients With Symptoms Suggestive of Coronary Artery Disease
Circulation
2002 ABSTRACT: In this large cohort of diabetics undergoing stress MPI, the presence and the extent of abnormal stress MPI independently predicted subsequent cardiac events. Using stress MPI in conjunction with clinical information can provide risk stratification of diabetic patients.
Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy
Journal of the American College of Cardiology
1996 ABSTRACT: We tested the hypothesis that percent achieved of predicted peak oxygen uptake (predicted V02max) improves the prognostic accuracy of identifying high risk ambulatory patients with congestive heart failure considered for heart transplantation compared with absolute peak oxygen uptake (V02max) in 181 patients with ischemic or dilated cardiomyopathy...
Gender Differences in the Noninvasive Evaluation and Management of Patients with Suspected Coronary Artery Disease
Annals of Internal Medicine
1994 ABSTRACT: Women with suspected coronary artery disease have fewer additional diagnostic tests than men after an initial abnormal noninvasive stress test result, even though the incidence of typical angina, cardiac risk factors, and initial diagnostic test positivity rates are similar.
Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses.
Circulation
1994 ABSTRACT: The physiological assessment of angiographically intermediate-severity stenoses remains problematic. Functional measurements of poststenotic intracoronary Doppler coronary flow reserve can be performed in humans but have not been correlated with hyperemic myocardial perfusion imaging or angiographic data in this patient population...
Clinical characteristics associated with sudden death in patients with variant angina
Circulation
1982 ABSTRACT: After hospital discharge, 114 patients with variant angina were followed for a mean period of 26 months. Six died suddenly and 13 others were resuscitated from sudden cardiac death. The extent of coronary disease and the prevalence of left ventricular ...
Social